Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19

SARS-CoV-2 antigen tests used at the point-of-care, such as the Abbott Panbio, have great potential to help combat the COVID-19 pandemic. The Panbio is Health Canada approved for the detection of SARS-CoV-2 in symptomatic individuals within the first 7 days of COVID-19 symptom onset(s). Symptomatic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Clin Microbiol Infect Dis
Main Authors: Stokes, William, Berenger, Byron M., Portnoy, Danielle, Scott, Brittney, Szelewicki, Jonas, Singh, Takshveer, Venner, Allison A., Turnbull, LeeAnn, Pabbaraju, Kanti, Shokoples, Sandy, Wong, Anita A., Gill, Kara, Guttridge, Tracy, Proctor, Dustin, Hu, Jia, Tipples, Graham
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979467/
https://ncbi.nlm.nih.gov/pubmed/33742322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10096-021-04202-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados